Selank for anxiety: what the actual research says

What did @glpn3e1 actually say?

Two hours after injecting selank, @glpn3e1 reports feeling "totally zen" at work. Over the previous week, they say they felt "way calmer, way less anxious." They work a standard corporate job in Sydney and frame the peptide as helping with general overwhelm rather than a clinical anxiety disorder. They also direct followers to an Instagram "peptide cheat sheet" that covers dosing and sourcing.

To be clear about what this is: a single person, one week in, reporting subjective mood changes after starting a compound that has no approved use in Australia or most Western countries. That is not nothing, but it is also nowhere near evidence. The claim is experiential, not medical. The concerning part is the casual referral to dosing and sourcing guidance, which we will get to.

Does the science back this up?

There is actual research on selank, which puts it ahead of many peptides on TikTok. The evidence base is small, dated, and almost entirely from Russian institutions, which matters for how you interpret it.

Selank is a synthetic analogue of the human tetrapeptide tuftsin. Russian research from the 1990s and 2000s, largely conducted at the Institute of Molecular Genetics in Moscow, reported anxiolytic effects in animal models and small human trials. A study by Semenova et al. (2010, Bulletin of Experimental Biology and Medicine) found reduced anxiety and improved cognitive performance in patients with anxiety-asthenic disorders treated with intranasal selank. A separate review by Zozulya et al. (2006, CNS Drug Reviews) described selank as modulating the GABAergic system and influencing serotonin metabolism, which would be plausible mechanisms for an anxiolytic effect.

However, these studies were small, not independently replicated in Western peer-reviewed trials, and conducted in clinical populations with diagnosed disorders, not healthy people managing workplace stress. The gap between "worked in a Russian clinical trial on anxious patients in 2006" and "pin it yourself and feel zen at your desk" is significant.

What did they get wrong (or right)?

Credit where it is due: selank is one of the more studied peptides in the anxiety space, and the mechanism of action is at least biologically coherent. Describing it as calming rather than claiming it treats a disease is a relatively responsible framing. They did not say it cures anxiety disorder, even though the hashtag "anxietydisorder" does some heavy lifting there.

What they got wrong, or at least glossed over, is substantial. First, one week of subjective experience is not a signal. Placebo effects in anxiety studies are robust and well-documented. A 2010 meta-analysis by Rief et al. (Journal of Affective Disorders) found placebo response rates in anxiety trials averaging around 30 to 40 percent. Second, selank is unregulated in Australia. The Therapeutic Goods Administration has not approved it. Sourcing it through unregulated channels, which the Instagram cheat sheet apparently facilitates, raises serious purity and contamination concerns. Third, directing a 5,300-person audience to a dosing guide for an unscheduled, unverified compound is where this crosses from personal anecdote into something more problematic.

What should you actually know?

Selank has a more credible preclinical and early clinical foundation than most peptides being discussed on social media right now. That bar is low, but it is real. The plausible mechanism involves GABA modulation and possible influence on BDNF expression, the latter supported by Kasian et al. (2012, Neurochemical Journal).

What the research does not support is self-administration based on a one-week TikTok testimonial. The studies that do exist used controlled doses in supervised clinical settings, not subcutaneous self-injection based on crowd-sourced cheat sheets. There are no long-term safety studies in humans. Peptide purity from gray-market suppliers is genuinely inconsistent, and injecting a contaminated compound carries infection and immune reaction risks that have nothing to do with the peptide itself.

If you are managing anxiety significant enough that you are seeking out research chemicals, that is worth a proper clinical conversation. There are evidence-based pharmacological and behavioral options with actual safety profiles. Selank is not there yet, scientifically speaking.